DAIC

JANUARY 8, 2024

Implanting the Penditure system during a minimally invasive mitral valve repair fixes two issues for the patient during one less traumatic procedure, leaving them with less pain and an easier recovery compared to surgery.”

Bicuspid/Mitral 124

Bicuspid/Mitral Atrial Fibrillation Anatomy Coronary Artery Disease 124

Frontiers in Cardiovascular Medicine

JANUARY 18, 2024

Adipose-derived mesenchymal stem cells (ASCs) represent an innovative candidate to treat ischemic heart disease (IHD) due to their abundance, renewable sources, minor invasiveness to obtain, and no ethical limitations. This prompts scientists to select optimal donors for clinical applications.

Heart Disease 64

Heart Disease Myocardial Infarction Transplant Atherosclerosis 64

Heart 2023 Conference

JANUARY 17, 2024

This institute is dedicated to pioneering research, innovation, and the development of clinically effective techniques for addressing various heart conditions. Koonlawee Nademanee, Director of the Bumrungrad Heart Institute in Thailand, have spearheaded the establishment of a world-class heart institute.

Congenital Heart Disease 49

Congenital Heart Disease Coronary Artery Disease Heart Transplant Transplant 49

Society of Thoracic Surgeons - Technology

JANUARY 19, 2022

Fiedler and Dr. Folesani to learn novel techniques, adapt innovative technology, and receive training from expert mentors who are dedicated to the highest standards of cardiothoracic surgery. Professor Large and his team are at the forefront of innovation with respect to nonthermic regional perfusion heart transplantation,” said Dr. Fiedler.

Cardiothoracic 52

Cardiothoracic Heart Transplant Allied Health Education 52

DAIC

FEBRUARY 14, 2025

Amputation statistics are bleak, and amputation should be a last resort, said Dr. Shishehbor, President of UH Harrington Heart & Vascular Institute, and Angela and James Hambrick Chair in Innovation at UH. This is why we are passionate about pursuing alternatives to amputation for our patients. When we save a limb, we save a life.

Hospital 52

Hospital Peripheral Arterial Disease Cancer Innovation 52

Global Cardiac Surgery

AUGUST 17, 2018

The “One Step Closer” series features high-impact non-governmental organizations and individuals, and innovative solutions bringing the world one step closer to cardiac surgery for all.

Open-Heart Surgery 52

Open-Heart Surgery Cardiothoracic Transplant Innovation 52

Cardiometabolic Health Congress

AUGUST 8, 2024

We need a comprehensive and innovative approach to cardiorenal metabolic management and risk reduction to address this challenge. These interconnected diseases pose a significant global health threat, with cardiovascular diseases alone accounting for one-third of all deaths worldwide , according to the World Health Organization.

Education 59

Education Cardiovascular Disease Diabetes Kidney Disease 59

DAIC

JUNE 24, 2024

At Endotronix, we firmly believe that innovation can drive patient care excellence in the home and ultimately change outcomes for patients with heart failure, one of the largest cost categories in healthcare. Secure messaging on a tablet between the clinical team, patient, and caregiver to support remote care.

Heart Failure 109

Heart Failure Reimbursement Heart Transplant Pulmonary 109

Cardiometabolic Health Congress

MARCH 8, 2024

Anuradha Lala-Trindade, MD: She focuses on the selection and care of patients with mechanical circulatory support devices and heart transplantation, genetic cardiomyopathies, and perioperative management of high-risk cardiac surgical cases. You can practically feel the energy and passion driving equal representation of women in medicine.

Cardiac Rehabilitation 59

Cardiac Rehabilitation Academic Diabetes Research 59

Frontiers in Cardiovascular Medicine

FEBRUARY 3, 2025

Finally, we discuss the role of gut microbiota in the treatment of atrial cardiomyopathy, including fecal microbiota transplantation and oral probiotics or prebiotics.

Cardiomyopathy 52

Cardiomyopathy Atrial Fibrillation Transplant Diet 52

Dr. Malcolm Kendrick

OCTOBER 30, 2024

(2022-25) Swiss Reinsurance Company: £645K China Kadoorie Biobank (2002-ongoing) AstraZeneca: $300K Bayer AG: £300K GlaxoSmithKline: £3.6M Elinogrel feasibility trial (2010-2011) Novartis: £500K EMPA-KIDNEY (2017-ongoing) Boehringer Ingelheim: £106.3M Establishing Fuwai-Oxford research centre (2010-ongoing) Merck: £1.1M

Cholesterol 145

Cholesterol Article Research Diet 145